News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.
A team of scientists led by Dr. Vaijayanti Kale, a former scientist of the Department of Biotechnology’s Pune-based National Centre for Cell Science (DBT-NCCS) and Prof. Jayesh Bellare of the Department of Chemical Engineering at IIT-Bombay has come up with a solution that could break the impasse.
DBT-National Institute of Biomedical Genomics (NIBMG), Kalyani an Autonomous Institute funded by the Department of Biotechnology, Government of India has created a database of genomic variations in oral cancer; the first of its kind in the world. NIBMG has made this database publicly-accessible.
Mild Cognitive Impairment & early form of Alzheimer’s is a condition in which memory deteriorates, but a person remains functionally independent. Among several treatment options, meditation is one non-invasive and cost-effective approach to bring relief to such patients.
Monday proved to be a historic and momentous day for the Ayush sector as five portals of importance were launched and four publications were released by the Union Minister of Ayush (IC) Shri Kiran Rijiju in an online event. The Minister also reminded that Ayush is going to play a big role in the National Digital Health Mission to provide health security to Indian people.
In the wake of the COVID-19 pandemic, and considering the enhanced production of COVID Vaccines, the Government proactively took the decision of setting up additional laboratories,to facilitate expedited testing / pre-release certification of the vaccines.
In an interesting development, a team of scientists at the Government of India’s Department of Biotechnology (DBT)’s National Brain Research Centre (NBRC), has identified Mulethi, a commonly used herb, as a potential source for the development of a drug against COVID-19.
Indian researchers have designed a robust, mobile group oxygen concentrator that can be used in rural settings and also be rapidly deployed in emergencies in any location.
About 50 countries, including Canada, Mexico, Nigeria and Panama, have shown interest in having a Co-WIN like system to run their vaccination drive, a senior official said Monday, adding India is ready to share the open source software free of cost.
Fulfilling its commitment, Serum Institute of India has produced over 10 crore doses of its Covid-19 vaccine Covishield in June so far as India ramps up the pace of its vaccination drive in the face of a possible third wave of the viral infection.
The Indian Institute of Technology in Delhi (IIT Delhi) on Friday launched a rapid diagnostic kit for conducting Covid-19 test at a price point of Rs50 apiece.
